ClinConnect ClinConnect Logo
Search / Trial NCT04841057

Biometabolic Outcomes After Weight Loss Surgery: An Individualized Approach

Launched by UNIVERSITY OF MISSOURI-COLUMBIA · Apr 8, 2021

Trial Information

Current as of July 26, 2025

Enrolling by invitation

Keywords

Gastric Bypass Intestinal Bypass Gut Microbiome Micro Rna Enteroendocrine Hormones Weight Recidivism Biliopancreatic Limb

ClinConnect Summary

Outcomes after weight loss surgery are quite variable with some patients regaining a significant amount of weight in the postoperative period. Increasing evidence suggests gastric bypass leads to weight loss and improvement in associated metabolic illness through mechanisms other than just restriction and malabsorption and may include circulating bile acids, gut hormones, genetic/epigenetic variability, changes in gut microbiota as well as other mechanisms. Whether modifications to bypassed intestine length may improve outcomes after gastric bypass has not been adequately studied with incon...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age greater than 18
  • 2. Body mass index of 40-60 kg/m2
  • 3. Meet insurance criteria, as set forth by the patient's insurance policy, to qualify for coverage for weight loss surgery
  • 4. Planned laparoscopic Roux-en-Y gastric bypass
  • 5. Willingness to have blood collected before and after surgical procedure at defined points and collect and mail stool sample before operation and at defined post-operative time points.
  • Exclusion Criteria:
  • 1. Age less than 18
  • 2. Patient fails to fulfill insurance mandated criteria
  • 3. Unwilling to be randomized to variable length to gastric bypass or unwilling to have blood collected or personally collect and mail in stool sample
  • 4. Unwilling to follow-up at required postoperative visits

About University Of Missouri Columbia

The University of Missouri-Columbia is a leading academic institution dedicated to advancing medical research and clinical innovation. As a prominent sponsor of clinical trials, the university leverages its extensive resources and expertise to facilitate groundbreaking studies aimed at improving patient outcomes across a variety of health conditions. With a commitment to ethical research practices and collaboration with multidisciplinary teams, the University of Missouri-Columbia strives to translate scientific discoveries into effective therapeutic interventions, ultimately enhancing the quality of care in the communities it serves.

Locations

Columbia, Missouri, United States

Patients applied

0 patients applied

Trial Officials

Andrew Wheeler, MD

Principal Investigator

University of Missouri-Columbia, Department of Surgery

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials